- Home
- FHTX vs TATT Comparison
FHTX vs TATT Comparison
Compare FHTX & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- TATT
- Stock Information
- Founded
- FHTX 2015
- TATT 1985
- Country
- FHTX United States
- TATT Israel
- Employees
- FHTX N/A
- TATT N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- TATT Aerospace
- Sector
- FHTX Health Care
- TATT Industrials
- Exchange
- FHTX Nasdaq
- TATT Nasdaq
- Market Cap
- FHTX 237.4M
- TATT 282.4M
- IPO Year
- FHTX 2020
- TATT 1987
- Fundamental
- Price
- FHTX $4.40
- TATT $31.09
- Analyst Decision
- FHTX Strong Buy
- TATT
- Analyst Count
- FHTX 5
- TATT 0
- Target Price
- FHTX $13.80
- TATT N/A
- AVG Volume (30 Days)
- FHTX 170.9K
- TATT 41.6K
- Earning Date
- FHTX 03-06-2025
- TATT 03-05-2025
- Dividend Yield
- FHTX N/A
- TATT N/A
- EPS Growth
- FHTX N/A
- TATT 43.74
- EPS
- FHTX N/A
- TATT 0.76
- Revenue
- FHTX $25,515,000.00
- TATT $142,909,000.00
- Revenue This Year
- FHTX N/A
- TATT $33.56
- Revenue Next Year
- FHTX $7.37
- TATT $14.09
- P/E Ratio
- FHTX N/A
- TATT $38.13
- Revenue Growth
- FHTX N/A
- TATT 36.36
- 52 Week Low
- FHTX $2.70
- TATT $10.51
- 52 Week High
- FHTX $10.25
- TATT $31.28
- Technical
- Relative Strength Index (RSI)
- FHTX 33.35
- TATT 68.23
- Support Level
- FHTX $4.13
- TATT $27.57
- Resistance Level
- FHTX $4.52
- TATT $31.28
- Average True Range (ATR)
- FHTX 0.34
- TATT 1.59
- MACD
- FHTX 0.08
- TATT 0.29
- Stochastic Oscillator
- FHTX 20.88
- TATT 85.30
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About TATT TAT Technologies Ltd.
TAT Technologies Ltd is a provider of solutions and services to the aerospace and defence industries focused mainly on the four segments: Original equipment manufacturing (OEM); MRO services for heat transfer; MRO services for aviation components; Overhaul and coating of jet engine components. The company designs, develops, and manufactures Heat Exchangers, Cooling Systems, Cold Plates, Vapor-Cycle Air Conditioning Systems (for both land and airborne applications), and flow accessories.